<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>5-<z:chebi fb="0" ids="35856">Lipoxygenase inhibitor</z:chebi> <z:chebi fb="0" ids="10112">zileuton</z:chebi> has been demonstrated to attenuate ischemic brain damage in rats of permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in previous work </plain></SENT>
<SENT sid="1" pm="."><plain>To further investigate the mechanism underlying <z:chebi fb="0" ids="10112">zileuton</z:chebi>'s neuroprotection, adult male Sprague-Dawley rats underwent permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), then received treatment with <z:chebi fb="0" ids="10112">zileuton</z:chebi> or vehicle after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Neurological deficit, <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, and morphological characteristic were measured 6 and 24 h after MCAO </plain></SENT>
<SENT sid="3" pm="."><plain>The enzymatic activity of myeloperoxidase (MPO) was assessed 6 and 24 h after MCAO and the <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation levels were evaluated by malondialdehyde assay </plain></SENT>
<SENT sid="4" pm="."><plain>Expression of nuclear factor-kappa B (NF-kappaB) p65 in rat brain was detected by immunohistochemistry and Western blot </plain></SENT>
<SENT sid="5" pm="."><plain>Expression of inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) in rat brain was determined by RT-PCR and Western blot </plain></SENT>
<SENT sid="6" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> production in rat brain was also measured 24 h after MCAO </plain></SENT>
<SENT sid="7" pm="."><plain>The concentration of TNF-alpha and IL-1beta in serum were detected by ELISA </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="10112">Zileuton</z:chebi> significantly reduced neurological deficit scores, cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, MPO activity, and the <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation levels </plain></SENT>
<SENT sid="9" pm="."><plain>It also inhibited the expression of NF-kappaB and decreased the expression and activity of iNOS in rat brain </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, <z:chebi fb="0" ids="10112">zileuton</z:chebi> attenuated the release of TNF-alpha and IL-1beta in serum </plain></SENT>
<SENT sid="11" pm="."><plain>Our results suggest that <z:chebi fb="0" ids="10112">zileuton</z:chebi> reduces inflammatory reaction and brain damage in a rat model of permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>The neuroprotective effect of <z:chebi fb="0" ids="10112">zileuton</z:chebi> in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> might be associated with the inhibition of inflammatory reaction </plain></SENT>
</text></document>